Cancer Genetics and Epigenetics, 2025, Vol.13, No.2, 50-61 http://medscipublisher.com/index.php/cge 61 Wang Z., Meng F.H., and Zhong Z., 2021, Emerging targeted drug delivery strategies toward ovarian cancer, Advanced Drug Delivery Reviews, 178: 113969. https://doi.org/10.1016/j.addr.2021.113969 Zhang Y.D., Cui Q.L., Xu M.M., Liu D., Yao S.Z., and Chen M., 2022, Current advances in PD-1/PD-L1 blockade in recurrent epithelial ovarian cancer, Frontiers in Immunology, 13: 901772. https://doi.org/10.3389/fimmu.2022.901772 Zhou J.R., 2024, Targeted therapy for specific genetic variations in cancer, International Journal of Clinical Case Reports, 14(2): 79-86. https://doi.org/10.5376/ijccr.2024.14.0010
RkJQdWJsaXNoZXIy MjQ4ODYzNA==